Author profile
Editorial team for Peptide Therapy Guide.
From this author
July 1, 2011 (Vol. 31, No. 13) Approaches Now Extend Implications of Technology Beyond Manipulation of Genes One of the most indispensable techniques in all areas of the life sciences is the use of expression …
Read guide →Membrane proteins are key biological players involved in myriad essential cellular processes from molecular transport, cellular communication, and signal transduction to maintaining structures within cells and…
Read guide →Gene editing has just started to fulfill its promise as a therapeutic modality. Further progress depends on making gene editing therapies more relevant to more patients. This was the theme of a recent talk by …
Read guide →Conventionally, oligonucleotides have been synthesized using phosphoramidite chemistry—a technique developed in 1981 and still used widely in basic and applied research.1 However, this approach has several lim…
Read guide →SAN DIEGO — Expect initial public offerings for biotechnology companies to continue to pop in the second half of 2026, driven by investors eager to back drug startups with quality clinical data in hand. In a M…
Read guide →RNA came to prominence during COVID-19 with mRNA vaccines saving millions of lives worldwide. Since then, the technology has evolved with some developers now focusing on personalized mRNA therapeutics rather t…
Read guide →A July report by a team of Jefferies analysts paints an upbeat picture for contract development and manufacturing organizations (CDMOs). Miyabi Yamakita and colleagues reported rising demand for the services o…
Read guide →In addition to COVID-19, viral diseases that are driving the development of mRNA-based vaccines range from influenza to genital herpes. These vaccines are forthcoming because mRNA development platforms are ver…
Read guide →Throughout his career, Luke Dannenberg, PhD, has held multiple positions in industry and academia that have put him in close proximity to oligonucleotide technologies. Trained as a scientist, he transitioned i…
Read guide →Chemify and Dewpoint Therapeutics have announced a partnership today to apply groundbreaking chemistry artificial intelligence (AI) to accelerate the discovery of molecules targeting cancer and neurodegenerati…
Read guide →The global synthetic biology market is projected to reach $30.7 billion by 2026 from $9.5 billion in 2021, at a compound annual growth rate of 26.5% during the forecast period, according to a report from Marke…
Read guide →In 1981, Genetic Engineering and Biotechnology News launched as the newspaper of record for the fledgling biotechnology industry. Publications come and go, but GEN has stayed the course for the past 40 years, …
Read guide →A Cleveland Clinic-led team of scientists and physicians has discovered that the immune checkpoint protein VISTA can directly turn off tumor-fighting T cells during immunotherapy and resist treatment. The team…
Read guide →Imagine a future where rare diseases and devastating cancers can be swiftly treated with therapies produced directly in the clinic and tailored to a patient’s unique genetic profile. Common conditions could be…
Read guide →Time: RNA-based therapeutics continue to impress the scientific community with rapid production, speed-to-market, and efficacious results. While conventional mRNA strategies have paved the way for this groundb…
Read guide →Dive Brief: - Sanofi will advance an experimental inflammatory disease drug into Phase 2 clinical testing after its biotechnology company partner Kymera Therapeutics reported Wednesday what it described as enc…
Read guide →April 15, 2013 (Vol. 33, No. 8) RNAi research has capitalized on the ability to design and deliver small interfering RNAs (siRNAs) or short hairpin RNAs (shRNAs) to knock down expression of target genes with s…
Read guide →Anthropic has released Claude Science, an AI workbench for scientists that consolidates fragmented research tools, including over 60 scientific databases and connectors pre-configured for genomics, proteomics,…
Read guide →Once labeled the “disease of kings” because of its association with consuming rich foods and alcohol, gout has emerged as a royal pain to a growing number of people. A 2024 study showed the prevalence of the m…
Read guide →Biomarker development is hardly coextensive with drug development, but in every developmental stage—from exploratory research to clinical trial to therapeutic application—there is significant overlap. As medic…
Read guide →